Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.
D015107:4-Butyrolactone / Q000037:antagonists & inhibitors*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D001971:Bromocriptine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism* / Q000502:physiology; D004873:Ergolines / Q000494:pharmacology*; D005663:Furans / Q000037:antagonists & inhibitors*; D006220:Haloperidol / Q000494:pharmacology*; D010479:Pergolide; D051381:Rats; D011919:Rats, Inbred Strains
D004873:Ergolines; D005663:Furans; D010479:Pergolide; D001971:Bromocriptine; D006220:Haloperidol; D015107:4-Butyrolactone; D004298:Dopamine